PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models (Q34627931)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models |
scientific article |
Statements
PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models (English)
K Dredge
E Hammond
P Handley
T J Gonda
C Vincent
R Brandt
V Ferro
1 February 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference